Previously, our group reported a new method for predicting outcomes based on prognostic markers, in which the expression levels of two genes: Insulin Like Growth Factor Binding Protein 6 (IGFBP6) and Elongation Of Very Long chain fatty acids protein 5 (ELOVL5) made it possible to predict breast cancer recurrence in the first 5 years of follow-up with high sensitivity (81.8%) and specificity (62.5%), while high expression of ELOVL5 and IGFBP6 corresponded to a favorable prognosis (Galatenko et al., 2015). Here, ELOVL5 is linked to breast cancer.